JP2013510324A - 高効率タンパク質発現の分泌タンパク質バイオマーカー - Google Patents
高効率タンパク質発現の分泌タンパク質バイオマーカー Download PDFInfo
- Publication number
- JP2013510324A JP2013510324A JP2012538076A JP2012538076A JP2013510324A JP 2013510324 A JP2013510324 A JP 2013510324A JP 2012538076 A JP2012538076 A JP 2012538076A JP 2012538076 A JP2012538076 A JP 2012538076A JP 2013510324 A JP2013510324 A JP 2013510324A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- subunit
- cell
- factor
- precursor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25952709P | 2009-11-09 | 2009-11-09 | |
| US61/259,527 | 2009-11-09 | ||
| US12/941,347 | 2010-11-08 | ||
| US12/941,347 US8524458B2 (en) | 2009-11-09 | 2010-11-08 | Secretory protein biomarkers for high efficiency protein expression |
| PCT/US2010/055953 WO2011057239A2 (en) | 2009-11-09 | 2010-11-09 | Secretory protein biomarkers for high efficiency protein expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2013510324A true JP2013510324A (ja) | 2013-03-21 |
Family
ID=43431809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012538076A Pending JP2013510324A (ja) | 2009-11-09 | 2010-11-09 | 高効率タンパク質発現の分泌タンパク質バイオマーカー |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8524458B2 (enExample) |
| EP (1) | EP2499254A2 (enExample) |
| JP (1) | JP2013510324A (enExample) |
| KR (1) | KR20120115494A (enExample) |
| CN (1) | CN102666873A (enExample) |
| AU (1) | AU2010314922A1 (enExample) |
| BR (1) | BR112012010976A2 (enExample) |
| CA (1) | CA2778254A1 (enExample) |
| IL (1) | IL219518A0 (enExample) |
| IN (1) | IN2012DN03358A (enExample) |
| MX (1) | MX2012005380A (enExample) |
| RU (1) | RU2012124114A (enExample) |
| WO (1) | WO2011057239A2 (enExample) |
| ZA (1) | ZA201202966B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016059359A (ja) * | 2014-09-22 | 2016-04-25 | 東洋紡株式会社 | バイオマーカーを用いた組換えタンパク質生産量の予測方法 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3255054A1 (en) * | 2016-06-06 | 2017-12-13 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for the purification of biological macromolecular complexes |
| CN108467890A (zh) * | 2018-05-02 | 2018-08-31 | 首都医科大学附属北京天坛医院 | Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品 |
| CN109470756B (zh) * | 2018-10-11 | 2020-08-25 | 昆明理工大学 | 测定14-3-3蛋白与质膜H+-ATPase蛋白互作的电化学方法 |
| CN117099743B (zh) * | 2023-07-11 | 2025-12-05 | 吉林大学 | 一种snx6基因不表达的异种移植供体及制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008054514A2 (en) * | 2006-04-21 | 2008-05-08 | Wyeth | Differential expression profiling analysis of cell culture phenotypes and the uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| US5302517A (en) * | 1987-06-16 | 1994-04-12 | The Board Of Regents Of The University Of Nebraska | Method of controlling the expression of a gene in a cell culture, cell culture vector used in the method and method of making the vector |
| DE68925971T2 (de) | 1988-09-23 | 1996-09-05 | Cetus Oncology Corp | Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US20050272055A1 (en) * | 2000-02-01 | 2005-12-08 | Rina Das | Method of treating lethal shock induced by toxic agents and diagnosing exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
| US8242057B2 (en) * | 2006-06-26 | 2012-08-14 | Cleveland Biolabs, Inc. | Methods for identifying modulators of apoptosis |
| EP2304434A2 (en) * | 2008-06-04 | 2011-04-06 | ProteoSys AG | Protein biomarkers for in vitro testing of developmental toxicity and embryotoxicity of chemical substances |
-
2010
- 2010-11-08 US US12/941,347 patent/US8524458B2/en not_active Expired - Fee Related
- 2010-11-09 IN IN3358DEN2012 patent/IN2012DN03358A/en unknown
- 2010-11-09 WO PCT/US2010/055953 patent/WO2011057239A2/en not_active Ceased
- 2010-11-09 EP EP10778803A patent/EP2499254A2/en not_active Withdrawn
- 2010-11-09 CA CA2778254A patent/CA2778254A1/en not_active Abandoned
- 2010-11-09 MX MX2012005380A patent/MX2012005380A/es not_active Application Discontinuation
- 2010-11-09 BR BR112012010976A patent/BR112012010976A2/pt not_active IP Right Cessation
- 2010-11-09 CN CN2010800503369A patent/CN102666873A/zh active Pending
- 2010-11-09 KR KR1020127014730A patent/KR20120115494A/ko not_active Withdrawn
- 2010-11-09 JP JP2012538076A patent/JP2013510324A/ja active Pending
- 2010-11-09 RU RU2012124114/10A patent/RU2012124114A/ru not_active Application Discontinuation
- 2010-11-09 AU AU2010314922A patent/AU2010314922A1/en not_active Abandoned
-
2012
- 2012-04-23 ZA ZA2012/02966A patent/ZA201202966B/en unknown
- 2012-05-01 IL IL219518A patent/IL219518A0/en unknown
-
2013
- 2013-08-30 US US14/016,035 patent/US20140004531A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008054514A2 (en) * | 2006-04-21 | 2008-05-08 | Wyeth | Differential expression profiling analysis of cell culture phenotypes and the uses thereof |
| JP2009534036A (ja) * | 2006-04-21 | 2009-09-24 | ワイス | 細胞培養表現型の示差的発現プロファイリング分析およびその使用 |
Non-Patent Citations (2)
| Title |
|---|
| JPN5013002688; SMALES C M: 'COMPARATIVE PROTEOMIC ANALYSIS OF GS-NSO MURINE MYELOMA CELL LINES WITH VARYING RECOMBINANT 以下備考' BIOTECHNOLOGY AND BIOENGINEERING V88 N4, 20041120, P474-488 * |
| JPN5013002691; WANG XIAO-PING: 'CO-EXPRESSION OF HEAT SHOCK PROTEIN 70 AND GLUCOSE-REGULATED PROTEIN 94 以下備考' WORLD JOURNAL OF GASTROENTEROLOGY V11 N23, 20050621, P3601-3604 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016059359A (ja) * | 2014-09-22 | 2016-04-25 | 東洋紡株式会社 | バイオマーカーを用いた組換えタンパク質生産量の予測方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2012005380A (es) | 2012-05-29 |
| CN102666873A (zh) | 2012-09-12 |
| AU2010314922A1 (en) | 2012-05-31 |
| WO2011057239A3 (en) | 2011-06-30 |
| US8524458B2 (en) | 2013-09-03 |
| KR20120115494A (ko) | 2012-10-18 |
| EP2499254A2 (en) | 2012-09-19 |
| IL219518A0 (en) | 2012-06-28 |
| WO2011057239A2 (en) | 2011-05-12 |
| BR112012010976A2 (pt) | 2016-08-16 |
| IN2012DN03358A (enExample) | 2015-10-23 |
| RU2012124114A (ru) | 2013-12-20 |
| CA2778254A1 (en) | 2011-05-12 |
| US20110236906A1 (en) | 2011-09-29 |
| US20140004531A1 (en) | 2014-01-02 |
| ZA201202966B (en) | 2012-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Deracinois et al. | Comparative and quantitative global proteomics approaches: an overview | |
| JP5682986B2 (ja) | 質量分析における安定同位体標識標的ペプチド断片の作製方法 | |
| Webb et al. | Modified MuDPIT separation identified 4488 proteins in a system-wide analysis of quiescence in yeast | |
| Rodríguez‐Suárez et al. | The application of quantification techniques in proteomics for biomedical research | |
| Ademowo et al. | Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis | |
| US11719703B2 (en) | Mass spectrometry technique for single cell proteomics | |
| Liu et al. | Deep profiling of microgram-scale proteome by tandem mass tag mass spectrometry | |
| de Graaf et al. | Set of novel automated quantitative microproteomics protocols for small sample amounts and its application to kidney tissue substructures | |
| Coombs | Quantitative proteomics of complex mixtures | |
| US20210095348A1 (en) | Methods and systems to perform genetically variant protein analysis, and related marker genetic protein variations and databases | |
| Dong et al. | A “tagless” strategy for identification of stable protein complexes genome-wide by multidimensional orthogonal chromatographic separation and iTRAQ reagent tracking | |
| US20140004531A1 (en) | Secretory Protein Biomarkers For High Efficiency Protein Expression | |
| Xu et al. | LC-MS multi-attribute method for characterization of biologics | |
| He et al. | On-capillary alkylation micro-reactor: a facile strategy for proteo-metabolome profiling in the same single cells | |
| US20250347698A1 (en) | Multi-Omics Biomarker Detection System and Methods for Disease Diagnostics | |
| Min et al. | Label-free quantitative proteomics and N-terminal analysis of human metastatic lung cancer cells | |
| Chen et al. | Applying multiple proteases to direct digestion of hundred‐scale cell samples for proteome analysis | |
| Meleady | Proteomic profiling of recombinant cells from large-scale mammalian cell culture processes | |
| Woo et al. | Robust, sensitive, and quantitative single-cell proteomics based on ion mobility filtering | |
| TW201140050A (en) | Secretory protein biomarkers for high efficiency protein expression | |
| Henry | Application of advanced liquid chromatography mass spectrometry to cancer and biopharmaceutical proteomics research | |
| Siva Piragasam | Discovery and Targeted Approaches for Comparative Label-Free Proteomic Quantification via Mass Spectrometry | |
| Feola et al. | PeptiCHIP: a novel microfluidic-based chip platform for tumour antigen landscape identification | |
| Florczak | Quantitative Analysis of Proteome Dynamics in Chinese Hamster Ovary Cells | |
| Farrell | Development and application of quantitative liquid chromatography–mass spectrometry techniques to facilitate enhanced bioprocessing of therapeutic proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20130701 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130822 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131101 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140625 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140708 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20141202 |